“For 20 years all I could do was tell my patients there were no cures, try to treat their symptoms, and fi ll out their disability forms,” she says. “With the development of molecular genetic technologies and the ability to identify responsible genes and understand their proteins, in the last decade we have begun to design treatments aimed at the disease itself. I am very optimistic about what lies ahead.”
Read more here (page 4): Partners in Discovery
skip to main |
skip to sidebar
No comments:
Post a Comment